{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:55:24Z","timestamp":1771880124080,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00044-016-1702-z","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T04:26:14Z","timestamp":1474345574000},"page":"2999-3010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Hypericum perforatum hydroalcoholic extract, hypericin, and hyperforin on cytotoxicity and CYP3A4 mRNA expression in hepatic cell lines: a comparative study"],"prefix":"10.1007","volume":"25","author":[{"given":"Ana","family":"Martinho","sequence":"first","affiliation":[]},{"given":"Sara M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Garcia","sequence":"additional","affiliation":[]},{"given":"Ivo","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Luiza Breitenfeld","family":"Granadeiro","sequence":"additional","affiliation":[]},{"given":"Gilberto","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Domingues","sequence":"additional","affiliation":[]},{"given":"Samuel","family":"Silvestre","sequence":"additional","affiliation":[]},{"given":"Eugenia","family":"Gallardo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"issue":"5","key":"1702_CR1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/0022357011775910","volume":"53","author":"J Barnes","year":"2001","unstructured":"Barnes J, Anderson LA, Phillipson JD (2001) St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53(5):583\u2013600","journal-title":"J Pharm Pharmacol"},{"issue":"26","key":"1702_CR2","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/S0024-3205(02)01566-7","volume":"70","author":"AR Bilia","year":"2002","unstructured":"Bilia AR, Gallori S, Vincieri FF (2002) St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci 70(26):3077\u20133096","journal-title":"Life Sci"},{"issue":"9218","key":"1702_CR3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/S0140-6736(05)73359-6","volume":"355","author":"T Breidenbach","year":"2000","unstructured":"Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J (2000) Drug interaction of St John's wort with cyclosporin. Lancet 355(9218):1912","journal-title":"Lancet"},{"issue":"1","key":"1702_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/toxsci\/kfg174","volume":"75","author":"L Cantoni","year":"2003","unstructured":"Cantoni L, Rozio M, Mangolini A, Hauri L, Caccia S (2003) Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse. Toxicol Sci 75(1):25\u201330","journal-title":"Toxicol Sci"},{"issue":"7","key":"1702_CR6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/dmd.109.027029","volume":"37","author":"V Chu","year":"2009","unstructured":"Chu V, Einolf HJ, Evers R, Kumar G, Moore D, Ripp S, Silva J, Sinha V, Sinz M, Skerjanec A (2009) In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective. Drug Metab Dispos 37(7):1339\u20131354","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1702_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1124\/dmd.32.1.28","volume":"32","author":"Y Cui","year":"2004","unstructured":"Cui Y, Ang CY, Beger RD, Heinze TM, Hu L, Leakey J (2004) In vitro metabolism of hyperforin in rat liver microsomal systems. Drug Metab Dispos 32(1):28\u201334","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"1702_CR5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0165-6147(00)01716-8","volume":"22","author":"G Carlo Di","year":"2001","unstructured":"Di Carlo G, Borrelli F, Ernst E, Izzo AA (2001) St John's wort: Prozac from the plant kingdom. Trends Pharmacol Sci 22(6):292\u2013297","journal-title":"Trends Pharmacol Sci"},{"key":"1702_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","volume":"43","author":"X Ding","year":"2003","unstructured":"Ding X, Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149\u2013173","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"8","key":"1702_CR9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s002280050519","volume":"54","author":"E Ernst","year":"1998","unstructured":"Ernst E, Rand JI, Barnes J, Stevinson C (1998) Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 54(8):589\u2013594","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1702_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/138920012798918426","volume":"13","author":"P Fasinu","year":"2012","unstructured":"Fasinu P, Bouic PJ, Rosenkranz B (2012) Liver-based in vitro technologies for drug biotransformation studies - a review. Curr Drug Metab 13(2):215\u2013224","journal-title":"Curr Drug Metab"},{"issue":"2","key":"1702_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00278.x","volume":"111","author":"FE Fox","year":"1998","unstructured":"Fox FE, Niu Z, Tobia A, Rook AH (1998) Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 111(2):327\u2013332","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1702_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","volume":"28","author":"HH Gerets","year":"2012","unstructured":"Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, Atienzar FA (2012) Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28(2):69\u201387","journal-title":"Cell Biol Toxicol"},{"issue":"4","key":"1702_CR13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130000625","volume":"153","author":"JM Greeson","year":"2001","unstructured":"Greeson JM, Sanford B, Monti DA (2001) St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl) 153(4):402\u2013414","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"1702_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","volume":"168","author":"A Guillouzo","year":"2007","unstructured":"Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C (2007) The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168(1):66\u201373","journal-title":"Chem Biol Interact"},{"issue":"6","key":"1702_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02634356","volume":"30A","author":"MC Gutierrez-Ruiz","year":"1994","unstructured":"Gutierrez-Ruiz MC, Bucio L, Souza V, Gomez JJ, Campos C, Carabez A (1994) Expression of some hepatocyte-like functional properties of WRL-68 cells in culture. In Vitro Cell Dev Biol Anim 30A(6):366\u2013371","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"6","key":"1702_CR16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clpt.2003.08.009","volume":"74","author":"SD Hall","year":"2003","unstructured":"Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC (2003) The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther 74(6):525\u2013535","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1702_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1742-7843.2007.00011.x","volume":"100","author":"BH Hellum","year":"2007","unstructured":"Hellum BH, Hu Z, Nilsen OG (2007) The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol 100(1):23\u201330","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"1702_CR18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1742-7843.2008.00227.x","volume":"102","author":"BH Hellum","year":"2008","unstructured":"Hellum BH, Nilsen OG (2008) In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 102(5):466\u2013475","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1702_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2010.12.002","volume":"42","author":"J Hokkanen","year":"2011","unstructured":"Hokkanen J, Tolonen A, Mattila S, Turpeinen M (2011) Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes. Eur J Pharm Sci 42(3):273\u2013284","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"1702_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/138920007779815995","volume":"8","author":"ZP Hu","year":"2007","unstructured":"Hu ZP, Yang XX, Chen X, Cao J, Chan E, Duan W, Huang M, Yu XQ, Wen JY, Zhou SF (2007) A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort. Curr Drug Metab 8(2):157\u2013171","journal-title":"Curr Drug Metab"},{"key":"1702_CR21","unstructured":"Ioannides C (1996) Cytochromes: metabolic and toxicological aspects. Taylor & Francis."},{"issue":"6","key":"1702_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00498250210124147","volume":"32","author":"C Ioannides","year":"2006","unstructured":"Ioannides C (2006) Topics in Xenobiochemistry - Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenebiotica 32(6):451\u2013478","journal-title":"Xenebiotica"},{"issue":"6","key":"1702_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0944-7113(00)80027-6","volume":"7","author":"V Jakovljevic","year":"2000","unstructured":"Jakovljevic V, Popovic M, Mimica-Dukic N, Sabo A, Gvozdenovic L (2000) Pharmacodynamic study of Hypericum perforatum L. Phytomedicine 7(6):449\u2013453","journal-title":"Phytomedicine"},{"issue":"Suppl 1","key":"1702_CR24","first-page":"93","volume":"29","author":"M Jarema","year":"2008","unstructured":"Jarema M (2008) Herbal drug treatment.. Neuro Endocrinol Lett 29(Suppl 1):93\u2013104","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"1702_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/toxsci\/kfq026","volume":"115","author":"DG Jennen","year":"2010","unstructured":"Jennen DG, Magkoufopoulou C, Ketelslegers HB, van Herwijnen MH, Kleinjans JC, van Delft JH (2010) Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci 115(1):66\u201379","journal-title":"Toxicol Sci"},{"issue":"7","key":"1702_CR26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","volume":"36","author":"KP Kanebratt","year":"2008","unstructured":"Kanebratt KP, Andersson TB (2008) Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos 36(7):1444\u20131452","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1702_CR27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms11020562","volume":"11","author":"A Karioti","year":"2010","unstructured":"Karioti A, Bilia AR (2010) Hypericins as potential leads for new therapeutics. Int J Mol Sci 11(2):562\u2013594","journal-title":"Int J Mol Sci"},{"key":"1702_CR28","doi-asserted-by":"crossref","unstructured":"Klemow KM, Bartlow A, Crawford J, Kocher N, Shah J and Ritsick M (2011) Medical attributes of St. John's Wort (hypericum perforatum). In: Benzie IFF & Wachtel-Galor S (eds) Herbal medicine: biomolecular and clinical aspects edited, 2nd edn. H Boca Raton (FL).","DOI":"10.1201\/b10787-12"},{"issue":"5","key":"1702_CR29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/dmd.32.5.512","volume":"32","author":"BJ Komoroski","year":"2004","unstructured":"Komoroski BJ, Zhang S, Cai H, Hutzler JM, Frye R, Tracy TS, Strom SC, Lehmann T, Ang CY, Cui YY, Venkataramanan R (2004) Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos 32(5):512\u2013518","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"1702_CR30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","volume":"102","author":"JM Lehmann","year":"1998","unstructured":"Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102(5):1016\u20131023","journal-title":"J Clin Invest"},{"issue":"3","key":"1702_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000209290","volume":"16","author":"K Linde","year":"2009","unstructured":"Linde K (2009) St. John's wort - an overview. Forsch Komplementmed 16(3):146\u2013155. (2006)","journal-title":"Forsch Komplementmed"},{"issue":"3","key":"1702_CR32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00228-006-0096-0","volume":"62","author":"R Madabushi","year":"2006","unstructured":"Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V (2006) Hyperforin in St. John's wort drug interactions. Eur J Clin Pharmacol 62(3):225\u2013233","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1702_CR33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ndt\/gfg002","volume":"18","author":"I Mai","year":"2003","unstructured":"Mai I, Stormer E, Bauer S, Kruger H, Budde K, Roots I (2003) Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 18(4):819\u2013822","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1702_CR34","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00894-010-0890-6","volume":"17","author":"J Mannu","year":"2011","unstructured":"Mannu J, Jenardhanan P, Mathur PP (2011) A computational study of CYP3A4 mediated drug interaction profiles for anti-HIV drugs. J Mol Model 17(8):1847\u20131854","journal-title":"J Mol Model"},{"issue":"11","key":"1702_CR35","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","volume":"290","author":"JS Markowitz","year":"2003","unstructured":"Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD (2003) Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290(11):1500\u20131504","journal-title":"JAMA"},{"issue":"1","key":"1702_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-012-9715-7","volume":"48","author":"A Martinho","year":"2012","unstructured":"Martinho A, Goncalves I, Costa M, Santos CR (2012) Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors. J Mol Neurosci 48(1):1\u201313","journal-title":"J Mol Neurosci"},{"issue":"1-2","key":"1702_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-012-1547-9","volume":"376","author":"A Martinho","year":"2013","unstructured":"Martinho A, Goncalves I, Santos CR (2013) Glucocorticoids regulate metallothionein-1\/2 expression in rat choroid plexus: effects on apoptosis. Mol Cell Biochem 376(1\u20132):41\u201351","journal-title":"Mol Cell Biochem"},{"issue":"16","key":"1702_CR38","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","volume":"94","author":"RH Mathijssen","year":"2002","unstructured":"Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A (2002) Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94(16):1247\u20131249","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"1702_CR39","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14):1639\u20131662","journal-title":"J Comput Chem"},{"issue":"16","key":"1702_CR40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"J Comput Chem"},{"issue":"1","key":"1702_CR41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00228-005-0061-3","volume":"62","author":"SC Mueller","year":"2006","unstructured":"Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, Sievers H, Bauer S, Frank B, Kundt G, Drewelow B (2006) The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol 62(1):29\u201336","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1702_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1043-6618(02)00266-9","volume":"47","author":"WE Muller","year":"2003","unstructured":"Muller WE (2003) Current St John's wort research from mode of action to clinical efficacy. Pharmacol Res 47(2):101\u2013109","journal-title":"Pharmacol Res"},{"issue":"Suppl 2","key":"1702_CR43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-979533","volume":"30","author":"A Nahrstedt","year":"1997","unstructured":"Nahrstedt A, Butterweck V (1997) Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 30(Suppl 2):129\u2013134","journal-title":"Pharmacopsychiatry"},{"key":"1702_CR44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1146\/annurev.bi.56.070187.004501","volume":"56","author":"DW Nebert","year":"1987","unstructured":"Nebert DW, Gonzalez FJ (1987) P450 genes: structure, evolution, and regulation. Annu Rev Biochem 56:945\u2013993","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"1702_CR45","doi-asserted-by":"crossref","first-page":"e111286","DOI":"10.1371\/journal.pone.0111286","volume":"9","author":"A Novotna","year":"2014","unstructured":"Novotna A, Krasulova K, Bartonkova I, Korhonova M, Bachleda P, Anzenbacher P, Dvorak Z (2014) Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2 Cells. PLoS One 9(10):e111286","journal-title":"PLoS One"},{"issue":"1","key":"1702_CR46","first-page":"88","volume":"294","author":"RS Obach","year":"2000","unstructured":"Obach RS (2000) Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 294(1):88\u201395","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1702_CR47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00003088-200746080-00005","volume":"46","author":"Y Ohno","year":"2007","unstructured":"Ohno Y, Hisaka A, Suzuki H (2007) General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Clin Pharmacokinet 46(8):681\u2013696","journal-title":"Clin Pharmacokinet"},{"issue":"13","key":"1702_CR48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"9","key":"1702_CR49","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1702_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12248-008-9027-6","volume":"10","author":"JE Polli","year":"2008","unstructured":"Polli JE (2008) In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms. AAPS J 10(2):289\u2013299","journal-title":"AAPS J"},{"issue":"10","key":"1702_CR51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/0091270006291623","volume":"46","author":"A Portoles","year":"2006","unstructured":"Portoles A, Terleira A, Calvo A, Martinez I, Resplandy G (2006) Effects of Hypericum perforatum on ivabradine pharmacokinetics in healthy volunteers: an open-label, pharmacokinetic interaction clinical trial. J Clin Pharmacol 46(10):1188\u20131194","journal-title":"J Clin Pharmacol"},{"issue":"1-2","key":"1702_CR52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","volume":"29","author":"S Rendic","year":"1997","unstructured":"Rendic S, Di Carlo FJ (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29(1\u20132):413\u2013580","journal-title":"Drug Metab Rev"},{"issue":"1","key":"1702_CR53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clpt.2005.01.024","volume":"78","author":"J Rengelshausen","year":"2005","unstructured":"Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T, Walter-Sack I, Haefeli WE, Mikus G (2005) Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics. Clin Pharmacol Ther 78(1):25\u201333","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1702_CR54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1067\/mcp.2000.106793","volume":"67","author":"CA Roby","year":"2000","unstructured":"Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH (2000) St John's Wort: effect on CYP3A4 activity. Clin Pharmacol Ther 67(5):451\u2013457","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1702_CR55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ptr.5050","volume":"28","author":"E Russo","year":"2014","unstructured":"Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patane M, Upton R, Pugliese M, Chimirri S, Mammi M, Palleria C, De Sarro G (2014) Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res 28(5):643\u2013655","journal-title":"Phytother Res"},{"issue":"3","key":"1702_CR56","first-page":"212","volume":"56","author":"HU Schulz","year":"2006","unstructured":"Schulz HU, Schurer M, Bassler D, Weiser D (2006) Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men. Arzneimittelforschung 56(3):212\u2013221","journal-title":"Arzneimittelforschung"},{"issue":"10","key":"1702_CR57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bbagen.2012.05.011","volume":"1820","author":"K Shahrokh","year":"2012","unstructured":"Shahrokh K, Cheatham 3rd TE, Yost GS (2012) Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen. Biochim Biophys Acta 1820(10):1605\u20131617","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"1702_CR58","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.285.15.1978","volume":"285","author":"RC Shelton","year":"2001","unstructured":"Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U (2001) Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 285(15):1978\u20131986","journal-title":"JAMA"},{"issue":"2","key":"1702_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1208\/s12248-008-9037-4","volume":"10","author":"M Sinz","year":"2008","unstructured":"Sinz M, Wallace G, Sahi J (2008) Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS J 10(2):391\u2013400","journal-title":"AAPS J"},{"issue":"4","key":"1702_CR60","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood-2004-04-1240","volume":"104","author":"PF Smith","year":"2004","unstructured":"Smith PF, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ (2004) Induction of imatinib metabolism by hypericum perforatum. Blood 104(4):1229\u20131230","journal-title":"Blood"},{"issue":"4","key":"1702_CR61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clpt.2003.12.012","volume":"75","author":"C Tannergren","year":"2004","unstructured":"Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennernas H (2004) St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 75(4):298\u2013309","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1702_CR62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/00912709922008173","volume":"39","author":"K Venkatakrishnan","year":"1999","unstructured":"Venkatakrishnan K, von Moltke LL, Greenblatt DJ (1999) Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs. J Clin Pharmacol 39(6):567\u2013577","journal-title":"J Clin Pharmacol"},{"issue":"1-2","key":"1702_CR63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jchromb.2007.02.026","volume":"852","author":"XD Wang","year":"2007","unstructured":"Wang XD, Li JL, Lu Y, Chen X, Huang M, Chowbay B, Zhou SF (2007) Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical herb-drug interaction study. J Chromatogr B Analyt Technol Biomed Life Sci 852(1\u20132):534\u2013544","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"1702_CR64","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI113156","volume":"80","author":"PB Watkins","year":"1987","unstructured":"Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, Guzelian PS (1987) Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 80(4):1029\u20131036","journal-title":"J Clin Invest"},{"issue":"1","key":"1702_CR65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clpt.2005.04.002","volume":"78","author":"HG Xie","year":"2005","unstructured":"Xie HG, Kim RB (2005) St John's wort-associated drug interactions: short-term inhibition and long-term induction? Clin Pharmacol Ther 78(1):19\u201324","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1702_CR66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1527-3458.2004.tb00022.x","volume":"10","author":"P Zanoli","year":"2004","unstructured":"Zanoli P (2004) Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev 10(3):203\u2013218","journal-title":"CNS Drug Rev"},{"issue":"4","key":"1702_CR67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","volume":"9","author":"SF Zhou","year":"2008","unstructured":"Zhou SF (2008) Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 9(4):310\u2013322","journal-title":"Curr Drug Metab"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-016-1702-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00044-016-1702-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-016-1702-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:12:15Z","timestamp":1498345935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00044-016-1702-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1007\/s00044-016-1702-z","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}